TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biotage Sweden AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
735,146
|
728,624
|
825,199 |
| Financial expenses |
9,889
|
1
|
28,403 |
| Earnings before taxes |
172,112
|
189,252
|
223,057 |
| EBITDA |
181,896
|
182,677
|
254,049 |
| Total assets |
628,045
|
681,332
|
548,708 |
| Current assets |
619,136
|
671,027
|
537,812 |
| Current liabilities |
367,032
|
260,892
|
251,973 |
| Equity capital |
251,314
|
411,548
|
289,249 |
| - share capital |
3,988
|
3,917
|
3,658 |
| Employees (average) |
85
|
92
|
93 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
40.0%
|
60.4%
|
52.7% |
| Turnover per employee |
8,649
|
7,920
|
8,873 |
| Profit as a percentage of turnover |
23.4%
|
26.0%
|
27.0% |
| Return on assets (ROA) |
29.0%
|
27.8%
|
45.8% |
| Current ratio |
168.7%
|
257.2%
|
213.4% |
| Return on equity (ROE) |
68.5%
|
46.0%
|
77.1% |
| Change turnover |
-6,616
|
-155,129
|
99,718 |
| Change turnover % |
-1%
|
-18%
|
14% |
| Chg. No. of employees |
-7
|
-1
|
-2 |
| Chg. No. of employees % |
-8%
|
-1%
|
-2% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.